Immix Biopharma, Inc.
US ˙ NasdaqCM ˙ US45258H1068

SecurityIMMX / Immix Biopharma, Inc.
InsiderGabriel S Morris
This page shows the track record and history of Morris Gabriel S insider trades in Immix Biopharma, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Gabriel S Morris in IMMX / Immix Biopharma, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-09-16 2,600 1.9700 2,600 1.9700 5,122 2 2.0900 312 6.09
2025-06-18 2,225 2.2790 2,225 2.2790 5,071
2024-06-07 2,500 2.1192 2,500 2.1192 5,298
2024-06-04 3,300 1.8099 3,300 1.8099 5,973
2024-05-14 4,500 2.2315 4,500 2.2315 10,042
2022-11-14 5,200 0.9400 5,200 0.9400 4,888
2021-12-20 2,000 5.0000 2,000 5.0000 10,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IMMX / Immix Biopharma, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Gabriel S Morris in IMMX / Immix Biopharma, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IMMX / Immix Biopharma, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-17 2025-09-16 4 Morris Gabriel S IMMX Common Stock P - Purchase D 1.9700 2,600 5 290,659
2025-06-20 2025-06-18 4 Morris Gabriel S IMMX Common Stock P - Purchase D 2.2790 2,225 5 288,059
2024-06-10 2024-06-07 4 Morris Gabriel S IMMX Common Stock P - Purchase D 2.1192 2,500 5 285,834
2024-06-05 2024-06-04 4 Morris Gabriel S IMMX Common Stock P - Purchase D 1.8099 3,300 6 283,334
2024-05-20 2024-05-20 4 Morris Gabriel S IMMX Common Stock A - Award I 24,141 24,141
2024-05-20 2024-05-20 4 Morris Gabriel S IMMX Common Stock A - Award I 24,141 24,141
2024-05-20 2024-05-20 4 Morris Gabriel S IMMX Common Stock A - Award D 194,218 280,034
2024-05-14 2024-05-14 4 Morris Gabriel S IMMX Common Stock P - Purchase D 2.2315 4,500 10 85,816
2022-11-15 2022-11-14 4 Morris Gabriel S IMMX Common Stock P - Purchase D 0.9400 5,200 5 81,316
2021-12-20 2021-12-20 4 Morris Gabriel S IMMX Convertible Note C - Conversion D 0.85 0
2021-12-20 2021-12-20 4 Morris Gabriel S IMMX Convertible Note C - Conversion I 0.85 0
2021-12-20 2021-12-20 4 Morris Gabriel S IMMX Convertible Note C - Conversion I 0.85 0
2021-12-20 2021-12-20 4 Morris Gabriel S IMMX Common Stock P - Purchase D 5.0000 2,000 10 76,116
2021-12-20 2021-12-20 4 Morris Gabriel S IMMX Common Stock C - Conversion I 0.8500 123,176 105 246,703
2021-12-20 2021-12-20 4 Morris Gabriel S IMMX Common Stock C - Conversion I 0.8500 123,527 105 123,527
2021-12-20 2021-12-20 4 Morris Gabriel S IMMX Common Stock C - Conversion D 0.8500 74,116 63 74,116
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)